ArticleFrontiers in oncology2024

Risk factors for immune-related adverse effects during CPI therapy in patients with head and neck malignancies - a single center study.

Frederic Jungbauer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.